Gene Therapies: The Moment of Truth

Are physicians and patients ready?

Gene therapy: moment of truth | Ipsos | White paperOffering new hope to patients suffering certain conditions, gene therapies are a class of medicines which have the potential to transform how conditions are treated and may even provide a cure.

While only a handful are currently approved globally, a rich and diverse developmental pipeline suggests the stage is set for change.

In our latest point of view, we use data from our syndicated Global Therapy Monitor and Conference Assessment Studies to highlight potential knowledge gaps among treating physicians when it comes to gene therapies. We also offer recommendations on how these gaps could be bridged to help amplify both physician and patient adoption of these therapies in the future.

Download the full paper

The author(s)

More insights about Health

Related news

  • The Human Advantage Conference 2026: Highlights

    The Human Advantage Conference 2026: Highlights

    Ipsos is proud to support The Human Advantage 2026, a flagship event bringing together some of the world's leading experts and key industry figures to explore how behavioural science, AI, and human intelligence can address the critical challenges facing businesses and society. Here's a look back at two days of live coverage.
  • [WEBINAR] KEYS: Dialling Up the S In Sustainability
    KEYS Events replay

    [REPLAY] KEYS: Dialling Up the S In Sustainability

    In the next episode of our KEYS webinar, we’ll be asking whether now is the time when organisations should be ‘dialling up the S’ in their sustainability initiatives.
  • [Webinar] Real-World Evidence: Empowering the Patient
    Healthcare Webinar

    [Replay] Real-World Evidence: Empowering the Patient

    Patient voices are now central to regulatory, HTA and commercial decisions. But how do we move beyond tick-box engagement to evidence that truly reflects lived experience? Join our expert panel for a 360° perspective on making patient-centricity work in practice.